Nice setup in $KPTI, I suggest buying these names with small positions considering the volatility that can occur after catalysts when new data is released, or around FDA approvals, etc. Upside can be substantial though, so if technicals and fundamentals align, it's worth keeping some exposure. Best of luck! Cheers, Ivan Labrie.
EYPT is now on another breakout on the 2h chart similar to what occurred from mid-December to mid-January. On the indicators the MACD shows the K/D lines on a steep upward slope. For me, what set off my interest was a relative volume scan that produced this stock on the list. The relative volume this week and consequential accumulation triggered the...
On the chart, we can se a falling wedge occurring. The stock has held its strong support for a long period of time, and we are now expecting it to go to the upside after bullish consolidation. MACD seems to make either a consolidating or bullish crossing. Our first target is based on the forming, while the second target hits our resistance level. Good luck!
I zoomed all the way out to the monthly chart to show the long-term support levels. We can see that HBIO is bouncing higher from a multi-year support level in the $2 range. The MACD (middle of the chart) didn't confirm an upward trend yet. However, the MACD did confirm the upward trend on the weekly chart. It looks like the blue monthly MACD line is close to...
Potentially longer term investment idea, showing signs of bottoming with bullish divergence on the 2D chart on the right www.ginkgobioworks.com
3/16/23 - Enzo Biochem (ENZ) stock is rising higher on an asset sale agreement. It’s selling its Clinical Laboratory division to Labcorp (LH). 3/20/23 - Monthly GD on MC. 8/23/23 - $3 per share.
$SAGE is an interesting stock here, has pending catalysts for mid 2023, which fit the expectations from the Time@Mode technical pattern at hand here. Consider the volatility of these biotech names when entering, stock could move huge after data comes out (up or down) but odds are good that it breaks to the upside given the technical pattern suggesting the smart...
It`s in our DNA to create reliable and objective analysis for our dear followers, and we will continue doing so. We can see a falling wedge occurring on this chart, and we therefore expect a move to the upside. Also the RSI has shown bullish divergence lately. We will wait for a breakout of the trend, to take our long position. More details are shown on the chart.
Greetings fellow traders and investors, The world events of the past year have had a profound impact on the global economy, and the crypto market has not been immune to these effects. As we move forward into the next period of capitalization, it is important to take a closer look at the current state of the crypto market and how it may be affected by the events...
$AUPH AUPH inside days after good run up and decent beat. Liquid and increasing institutional interest.
$ZLAB is an interesting biotech stock, with a couple potentially explosive catalysts during 2023. There's a nice weekly signal here indicating the stock is accumulated and ready to move up strongly over time. Remember to size these names considering the extreme volatility that can occur after drug trial data comes out, or if they receive an FDA approval, etc. Best...
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial...
Biontech SE ADR $130 PREDICTED LIVE This stock move is called a bounce, rock, algo skate. Pillar worthy
48 PER broken the 14 year trend lchannel also the lower sloping 3 year ( red Channel)
I think this has a range to stay within if its going to survive Ideally it will stay within the 86 to 70 cent region, any further break down and we are in no mans land. Even now we are in uncharted waters for this stock which has traditionally show much support and bounce at $1.45 Sub $1 can either be a steal or bad news bears. would DCA in this position and...
Immunocore Holdings is a commercial-stage T cell receptor biotechnology company working to develop and commercialize transformative medicines for oncology, infectious diseases and autoimmune and inflammation diseases. In a confirmed uptrend, yesterday signaled a good pivot buy where I placed an initial position. I liked the volatility contraction pattern and...
$ABCL a favorite long term but risk ahead if markets falter as revenue from Covid treatment stops coming in
Currently trading mid 4's with a market cap under 100 million it's way to cheap for the Robust pipeline including the recent addition from Taurus adensonine pipeline Structure Shs Outstand 16.74M Shs Float 10.13M Expect Catalyst Data readouts from pipeline Research Pipeline Merck, lead asset Port-2 (inkt)/trial designed with Merck Technical Bottom